Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 159,240 | 259,775 | 102,891 | 80,259 | 72,920 |
| Marketable Securities | 0 | N/A | 14,857 | 50,818 | 71,792 |
| Receivables | 313,568 | 284,145 | 260,522 | 216,511 | 141,308 |
| Inventories | 62,162 | 61,978 | 62,605 | 66,783 | 63,989 |
| Other current assets | 13,782 | 14,081 | 11,099 | 16,222 | 17,897 |
| TOTAL | $557,931 | $627,477 | $475,631 | $444,365 | $385,484 |
| Non-Current Assets | |||||
| PPE Net | 3,334 | 4,188 | 5,119 | 6,069 | 6,929 |
| Intangibles | 55,455 | 57,104 | 71,673 | 0 | 0 |
| Other Non-Current Assets | 58,135 | 74,776 | 77,181 | 133,349 | 77,178 |
| TOTAL | $116,924 | $136,068 | $153,973 | $139,418 | $84,107 |
| Total Assets | $674,855 | $763,545 | $629,604 | $583,783 | $469,591 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 175,000 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 76,818 | 38,289 | 35,219 | 37,092 | 29,278 |
| Accrued Expenses | 386,187 | 325,014 | 296,552 | 202,567 | 140,162 |
| TOTAL | $463,005 | $538,303 | $331,771 | $239,659 | $169,440 |
| Non-Current Liabilities | |||||
| Long Term Debt | 36,541 | 72,452 | 246,481 | 246,217 | 245,963 |
| Other Non-Current Liabilities | 259,417 | 234,634 | 244,777 | 231,506 | 228,952 |
| TOTAL | $295,958 | $307,086 | $491,258 | $477,723 | $474,915 |
| Total Liabilities | $758,963 | $845,389 | $823,029 | $717,382 | $644,355 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 115,209 | 114,726 | 112,715 | 111,364 | 94,469 |
| Common Shares | 12 | 11 | 11 | 11 | 9 |
| Retained earnings | -1,489,546 | -1,476,625 | -1,579,500 | -1,499,847 | -1,460,206 |
| Other shareholders' equity | -272 | -272 | -248 | -265 | -297 |
| TOTAL | $-84,108 | $-81,844 | $-193,425 | $-133,599 | $-174,764 |
| Total Liabilities And Equity | $674,855 | $763,545 | $629,604 | $583,783 | $469,591 |